CN102920792B - Processed product of polygala tenuifolia with mangnolia officinalis and preparation method of same - Google Patents
Processed product of polygala tenuifolia with mangnolia officinalis and preparation method of same Download PDFInfo
- Publication number
- CN102920792B CN102920792B CN201210482642.0A CN201210482642A CN102920792B CN 102920792 B CN102920792 B CN 102920792B CN 201210482642 A CN201210482642 A CN 201210482642A CN 102920792 B CN102920792 B CN 102920792B
- Authority
- CN
- China
- Prior art keywords
- magnolia
- polygala
- juice
- officinalis
- bark
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 45
- 241001080798 Polygala tenuifolia Species 0.000 title description 2
- 241000208966 Polygala Species 0.000 claims abstract description 250
- 241001673966 Magnolia officinalis Species 0.000 claims abstract description 234
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 178
- 241000218378 Magnolia Species 0.000 claims abstract description 89
- 239000003814 drug Substances 0.000 claims abstract description 70
- 229940079593 drug Drugs 0.000 claims abstract description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 55
- 239000000463 material Substances 0.000 claims abstract description 54
- 206010042496 Sunburn Diseases 0.000 claims abstract description 25
- 239000012141 concentrate Substances 0.000 claims description 55
- 238000002791 soaking Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 57
- 230000002496 gastric effect Effects 0.000 abstract description 27
- 238000000034 method Methods 0.000 abstract description 15
- 230000001914 calming effect Effects 0.000 abstract description 11
- 230000005176 gastrointestinal motility Effects 0.000 abstract description 9
- 230000000954 anitussive effect Effects 0.000 abstract description 7
- 230000003419 expectorant effect Effects 0.000 abstract description 6
- 210000005036 nerve Anatomy 0.000 abstract description 6
- 229940124584 antitussives Drugs 0.000 abstract description 4
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 abstract description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 3
- 239000003172 expectorant agent Substances 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 208000026435 phlegm Diseases 0.000 abstract description 3
- VVOAZFWZEDHOOU-UHFFFAOYSA-N honokiol Natural products OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 58
- 239000000047 product Substances 0.000 description 55
- 241000699670 Mus sp. Species 0.000 description 51
- 239000007788 liquid Substances 0.000 description 46
- 238000012360 testing method Methods 0.000 description 41
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- 239000000243 solution Substances 0.000 description 32
- 229930182432 Polygalasaponin Natural products 0.000 description 29
- 238000002474 experimental method Methods 0.000 description 26
- 239000013558 reference substance Substances 0.000 description 26
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 description 16
- FVYXIJYOAGAUQK-UHFFFAOYSA-N honokiol Chemical compound C1=C(CC=C)C(O)=CC=C1C1=CC(CC=C)=CC=C1O FVYXIJYOAGAUQK-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 230000000968 intestinal effect Effects 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 10
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 10
- 238000011084 recovery Methods 0.000 description 9
- 238000012449 Kunming mouse Methods 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 8
- 230000037396 body weight Effects 0.000 description 8
- 210000001187 pylorus Anatomy 0.000 description 8
- 210000000813 small intestine Anatomy 0.000 description 8
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 7
- 235000011114 ammonium hydroxide Nutrition 0.000 description 7
- 239000003610 charcoal Substances 0.000 description 7
- 229960002275 pentobarbital sodium Drugs 0.000 description 7
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000005464 sample preparation method Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000013112 stability test Methods 0.000 description 6
- DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 description 5
- 238000000581 reactive spray deposition Methods 0.000 description 5
- 230000001624 sedative effect Effects 0.000 description 5
- 210000003437 trachea Anatomy 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 210000000683 abdominal cavity Anatomy 0.000 description 4
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical group N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 230000000147 hypnotic effect Effects 0.000 description 3
- 238000001543 one-way ANOVA Methods 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical class [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 235000009161 Espostoa lanata Nutrition 0.000 description 2
- 240000001624 Espostoa lanata Species 0.000 description 2
- 208000017228 Gastrointestinal motility disease Diseases 0.000 description 2
- 241000202807 Glycyrrhiza Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000694540 Pluvialis Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 210000002318 cardia Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 239000012982 microporous membrane Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 229960005132 cisapride Drugs 0.000 description 1
- DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000000534 thyroid cartilage Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于医药领域,具体涉及厚朴炙远志炮制品及其制备方法。本发明所解决的技术问题是厚朴炙远志炮制品,用于缓解远志的胃肠副作用,并保留远志“宁心安神,祛痰开窍”的功效。本发明厚朴炙远志炮制品是由下述方法制备:A、厚朴与远志按生药比为:厚朴1-3份、远志1份;优选厚朴2份、远志1份;B、制备厚朴汁:取厚朴药材加水煎煮,过滤得厚朴汁;C.厚朴汁炙远志:取步骤B所得厚朴汁浸泡远志,至远志吸收厚朴汁,在60-180℃炒炙6-18min,待收汁后,干燥即得厚朴炙远志炮制品。本发明厚朴炙远志炮制品能有效降低生远志的胃肠动力抑制副作用,且能保留镇咳、祛痰、安神药效,达到了减副存效的目的,具有临床应用价值。
The invention belongs to the field of medicine, and in particular relates to a processed product of Magnolia officinalis Radix Polygalae and a preparation method thereof. The technical problem solved by the present invention is the processed product of Magnolia officinalis Polygala, which is used to alleviate the gastrointestinal side effects of Polygala, and retain the effect of Polygala "calming the mind, calming the nerves, eliminating phlegm and resuscitation". The processed product of Magnolia officinalis Radix Polygalae of the present invention is prepared by the following method: A, Magnolia officinalis and Polygala are according to crude drug ratio: 1-3 parts of Magnolia officinalis, 1 part of Polygala; 2 parts of Magnolia officinalis, 1 part of Polygala; B, preparation Magnolia officinalis juice: take Magnolia officinalis medicinal materials, add water to decoct, and filter to obtain Magnolia officinalis juice; C. Sunburn Polygala with Magnolia Juice: Soak Polygala with Magnolia Juice obtained in step B until Polygala absorbs Magnolia Juice, stir-fry and roast at 60-180°C for 6-18 minutes, after the juice is collected, dry to obtain processed Magnolia Polygala. The processed product of Magnolia Radix Polygalae of the present invention can effectively reduce the gastrointestinal motility inhibitory side effect of Radix Polygalae, and can retain the effects of antitussive, expectorant, and calming drugs, thereby achieving the purpose of reducing side effects and saving efficacy, and has clinical application value.
Description
技术领域technical field
本发明属于医药领域,具体涉及厚朴炙远志炮制品及其制备方法。The invention belongs to the field of medicine, and in particular relates to a processed product of Magnolia officinalis Radix Polygalae and a preparation method thereof.
背景技术Background technique
远志为传统的安神中药,有安神定志之功,主要用于心神不安,惊悸失眠,健忘等证的治疗。现代药理研究表明,远志提取物对中枢神经系统有镇静、抗惊厥作用,其根皮、全根及木心灌喂给予小鼠,有镇静安神作用。但远志生品的毒性较大,研究显示生远志能显著抑制胃肠动力,并妨碍胃肠消化功能,呈现明显的胃肠胀气,胃黏膜损伤及消化酶受抑等副作用。临床使用安全性低,制约着远志在临床安全、有效的应用。Polygala is a traditional traditional Chinese medicine for calming the nerves and calming the nerves. It is mainly used for the treatment of restlessness, palpitations, insomnia, and forgetfulness. Modern pharmacological studies have shown that Polygala extract has sedative and anticonvulsant effects on the central nervous system, and its root bark, whole root and wood heart are fed to mice, which has a sedative and tranquilizing effect. However, raw polygala is highly toxic. Studies have shown that raw polygala can significantly inhibit gastrointestinal motility, hinder gastrointestinal digestion, and present obvious side effects such as flatulence, gastric mucosal damage, and inhibition of digestive enzymes. The low safety of clinical use restricts the safe and effective clinical application of polygala.
本发明的发明人曾研制出中国专利申请200510021948.6,所涉及的蜜炙远志可降低其胃粘膜损伤,部分缓解胃肠动力抑制。发明人还曾经以厚朴与远志配伍同煎以改善其胃肠道副作用,如《远志与厚朴配伍前后化学成分对比及解毒机理初步研究》[成都中医药大学,2009年硕士论文],《远志、厚朴及其不同配比对家兔离体肠平滑肌的影响》[中药药理与临床2011年第03期],《远志与厚朴不同煎煮时间及不同配比对小鼠胃肠运动的影响》[西安交通大学学报(医学版)2009年第03期],具体考察了厚朴、远志不同配伍关系下,厚朴后下与远志同煎及煎煮条件,对缓解远志的胃肠副作用的影响,其结果是以特定配比同煎能有效缓解远志的胃肠副作用,并能保留远志“宁心安神,祛痰开窍”的功效。The inventor of the present invention has developed the Chinese patent application 200510021948.6, the involved honey-roasted polygala can reduce the damage of its gastric mucosa and partially relieve the inhibition of gastrointestinal motility. The inventor also used Magnolia officinalis and Polygala to improve its gastrointestinal side effects, such as "Comparison of chemical components and detoxification mechanism of Polygala and Magnolia before and after compatibility" [Chengdu University of Traditional Chinese Medicine, 2009 master's thesis], " Effects of polygala, Magnolia officinalis and their different ratios on isolated intestinal smooth muscle of rabbits" [Chinese medicine pharmacology and clinical 2011 No. 03], "Polygala and Magnolia officinalis with different decoction time and different ratios on gastrointestinal motility in mice "[Journal of Xi'an Jiaotong University (Medical Edition) 2009 No. 03], specifically investigated the effect of different compatibility of Magnolia officinalis and Polygala on the gastrointestinal The effect of side effects, the result is that decoction with a specific ratio can effectively relieve the gastrointestinal side effects of Polygala, and can retain the effect of Polygala "calming the mind, calming the nerves, eliminating phlegm and resuscitation".
本发明的发明人在此基础上提供一种全新的远志炮制品用于改善远志的胃肠道副作用。On this basis, the inventors of the present invention provide a brand-new processed product of polygala for improving the gastrointestinal side effects of polygala.
发明内容Contents of the invention
本发明所解决的技术问题是厚朴炙远志炮制品,用于缓解远志的胃肠副作用,并保留远志“宁心安神,祛痰开窍”的功效。The technical problem solved by the present invention is the processed product of Magnolia officinalis Polygala, which is used to alleviate the gastrointestinal side effects of Polygala, and retain the effect of Polygala "calming the mind, calming the nerves, eliminating phlegm and resuscitation".
本发明厚朴炙远志炮制品是由下述方法制备:Magnolia Radix Polygalae processed product of the present invention is prepared by following method:
A、厚朴与远志按生药比为:厚朴1-3份、远志1份;优选厚朴2份、远志1份;A. Magnolia officinalis and polygala according to crude drug ratio: 1-3 parts of Magnolia officinalis, 1 part of polygala; preferably 2 parts of Magnolia officinalis, 1 part of polygala;
B、制备厚朴汁:取厚朴药材加水煎煮,过滤得厚朴汁;B, preparation of Magnolia officinalis juice: get Magnolia officinalis medicinal material, add water to decoct, filter to obtain Magnolia officinalis juice;
C.厚朴汁炙远志:取步骤B所得厚朴汁浸泡远志,至远志吸收厚朴汁,在60-180℃炒炙6-18min,待收汁后,干燥即得厚朴炙远志炮制品。C. Sunburn Polygala with Magnolia Juice: Soak Polygala with Magnolia Juice obtained in step B until Polygala absorbs Magnolia Juice, stir-fry and roast at 60-180°C for 6-18 minutes, after the juice is collected, dry to obtain processed Magnolia Polygala.
以下为本发明厚朴炙远志炮制品制备方法的进一步优选工艺:The following is a further preferred process of the preparation method of Magnolia officinalis Radix Polygalae processed product of the present invention:
进一步的,步骤B中厚朴的加水量为8-12倍量。Further, the amount of water added to Magnolia officinalis in step B is 8-12 times the amount.
进一步的,步骤B中厚朴煎煮前加水浸泡的时间为15-45min,优选30min。Further, in step B, the time for soaking Magnolia officinalis in water before decocting is 15-45min, preferably 30min.
进一步的,步骤B中厚朴煎煮时间为5-15min,优选10min。Further, the magnolia bark decocting time in step B is 5-15min, preferably 10min.
进一步的,为了减少步骤C厚朴汁浸泡远志的时间,可以在步骤B将过滤后的厚朴汁浓缩至远志的0.2-0.8量,即按远志生药50g计,步骤B将过滤后的厚朴汁浓缩成10-40ml,便于吸收。Further, in order to reduce the time for soaking Polygala juice in step C, the filtered Magnolia juice can be concentrated to 0.2-0.8 amount of Polygala in step B, that is, based on 50 g of Polygala crude drug, step B will filter Magnolia bark The juice is concentrated into 10-40ml for easy absorption.
进一步的,步骤C中炒炙温度优选120℃。Further, the frying temperature in step C is preferably 120°C.
进一步的,步骤C中炒炙时间优选12min。Further, the frying time in step C is preferably 12 minutes.
本发明厚朴炙远志炮制品能有效降低生远志的胃肠动力抑制副作用,且能保留镇咳、祛痰、安神药效,达到了减副存效的目的,具有临床应用价值。The processed product of Magnolia Radix Polygalae of the present invention can effectively reduce the gastrointestinal motility inhibitory side effect of Radix Polygalae, and can retain the effects of antitussive, expectorant, and calming drugs, thereby achieving the purpose of reducing side effects and saving efficacy, and has clinical application value.
附图说明Description of drawings
图1混合对照品色谱图。Figure 1 is the chromatogram of the mixed reference substance.
图2远志20分钟药液阴性对照色谱图。Figure 2 The chromatogram of the negative control of Polygala 20 minutes medicinal solution.
图3和厚朴酚对照品质量与峰面积标准曲线。Figure 3 Honokiol reference substance mass and peak area standard curve.
图4厚朴酚对照品质量与峰面积标准曲线。Figure 4 Magnolol reference substance quality and peak area standard curve.
图5厚朴10分钟药液供试品的酚性成分色谱图。The chromatogram of the phenolic component of Fig. 5 Magnolia officinalis 10 minutes medical solution test sample.
图6炮制品5供试品的酚性成分色谱图。The chromatogram of the phenolic component of Fig. 6 processed product 5 test samples.
图7细叶远志皂苷对照品色谱图。Fig. 7 Chromatogram of polygala saponin reference substance.
图8厚朴10分钟药液阴性对照色谱图。Figure 8 Magnolia officinalis 10-minute medicinal liquid negative control chromatogram.
图9细叶远志皂苷对照品质量与峰面积标准曲线。Fig. 9 standard curve of quality and peak area of Polygala saponin reference substance.
图10远志20分钟药液供试品的细叶远志皂苷色谱图。Fig. 10 Polygala saponin chromatogram of the 20-minute medicinal liquid test sample of Polygala.
图11炮制品5供试品的细叶远志皂苷色谱图。Fig. 11 The chromatogram of polygala saponin of processed product 5 test sample.
具体实施方式Detailed ways
一、实验研究1. Experimental research
1实验材料1 Experimental materials
1.1实验动物1.1 Experimental animals
昆明种小鼠,18~22g,由成都中医药大学实验动物中心提供,合格证号:scxk(川)2009-11。Kunming mice, 18-22 g, were provided by the Experimental Animal Center of Chengdu University of Traditional Chinese Medicine, certificate number: scxk (Sichuan) 2009-11.
1.2受试药物、主要试剂、药品及仪器1.2 Test drugs, main reagents, drugs and instruments
1.2.1受试药物1.2.1 Test drugs
远志:购于成都市荷花池中药材市场,经成都中医药大学卢先明教授鉴定为远志科远志Polygala tenuifolia willd的根,属于2010版《中国药典》收载品种。Polygala: purchased from the Hehuachi Traditional Chinese Medicine Market in Chengdu, identified as the root of Polygala tenuifolia willd by Professor Lu Xianming of Chengdu University of Traditional Chinese Medicine, and belongs to the species recorded in the 2010 edition of "Chinese Pharmacopoeia".
厚朴:购于成都市荷花池中药材市场,经成都中医药大学卢先明教授鉴定为厚朴Magnolia officinalis Rehd.et Wils.及凹叶厚朴Magnolia officinalis Rehd.et Wils.var.biloba Rehd.et Wils.的根皮,为2010版《中国药典》收载品种。Magnolia Officinalis: Bought from the Hehuachi Traditional Chinese Medicine Market in Chengdu, identified as Magnolia officinalis Rehd.et Wils. and Magnolia officinalis Rehd.et Wils.var.biloba Rehd.et Wils. by Professor Lu Xianming of Chengdu University of Traditional Chinese Medicine Root bark is a species recorded in the 2010 edition of "Chinese Pharmacopoeia".
1.2.2主要试剂、药品1.2.2 Main reagents and drugs
苯酚红,成都市科龙化工试剂厂,生产批号:0100901Phenol red, Chengdu Kelong Chemical Reagent Factory, production batch number: 0100901
安定,常州四药制药有限公司,生产批号:20111108Anding, Changzhou Siyao Pharmaceutical Co., Ltd., production batch number: 20111108
氯化铵,成都市科龙化工试剂厂,生产批号:110308Ammonium chloride, Chengdu Kelong Chemical Reagent Factory, production batch number: 110308
西沙必利,浙江京新药业股份有限公司,生产批号:1012161Cisapride, Zhejiang Jingxin Pharmaceutical Co., Ltd., production batch number: 1012161
复方甘草片,青海制药厂有限公司,生产批号:20111246Compound Licorice Tablets, Qinghai Pharmaceutical Factory Co., Ltd., production batch number: 20111246
戊巴比妥钠,北京化学试剂公司,生产批号:Q/H82-F158-2002Sodium pentobarbital, Beijing Chemical Reagent Company, production batch number: Q/H82-F158-2002
甲醇,分析纯,成都市科龙化工试剂厂,生产批号:20120327Methanol, analytically pure, Chengdu Kelong Chemical Reagent Factory, production batch number: 20120327
氢氧化钠,分析纯,成都市科龙化工试剂厂,生产批号:20110921Sodium hydroxide, analytically pure, Chengdu Kelong Chemical Reagent Factory, production batch number: 20110921
磷酸,分析纯,上海化学试剂总厂,生产批号:20080625Phosphoric acid, analytically pure, Shanghai Chemical Reagent General Factory, production batch number: 20080625
氨水,分析纯,成都市科龙化工试剂厂,生产批号:20110418Ammonia water, analytically pure, Chengdu Kelong Chemical Reagent Factory, production batch number: 20110418
正丁醇,分析纯,成都市科龙化工试剂厂,生产批号:20110826Butanol, analytically pure, Chengdu Kelong Chemical Reagent Factory, production batch number: 20110826
纯净水,乐百氏(广东)饮用水有限公司成都分公司Purified water, Robust (Guangdong) Drinking Water Co., Ltd. Chengdu Branch
色谱甲醇,色谱纯,Fisher公司,生产批号:111270Chromatographic methanol, chromatographically pure, Fisher company, production batch number: 111270
厚朴酚对照品,成都曼斯特生物科技有限公司,纯度≥98%,生产批号:11050601Magnolol reference substance, Chengdu Master Biotechnology Co., Ltd., purity ≥ 98%, production batch number: 11050601
和厚朴酚对照品,成都曼斯特生物科技有限公司,纯度≥98%,生产批号:11050602Honokiol reference substance, Chengdu Master Biotechnology Co., Ltd., purity ≥ 98%, production batch number: 11050602
细叶远志皂苷对照品,成都曼斯特生物科技有限公司,纯度≥98%,生产批号:11042801Polygala saponin reference substance, Chengdu Master Biotechnology Co., Ltd., purity ≥ 98%, production batch number: 11042801
1.2.3实验仪器1.2.3 Experimental Instruments
CP124S电子分析天平(SARTORIUS)CP124S electronic analytical balance (SARTORIUS)
VARIOSKAN FLASH 2.4.3全波长多功能读数仪(Thermo公司)VARIOSKAN FLASH 2.4.3 full-wavelength multi-function reader (Thermo Company)
岛津LC-20AT高效液相色谱仪(SHIAZDU公司)Shimadzu LC-20AT high performance liquid chromatography (SHIAZDU company)
微量进样器(25ul,Hamilton公司)Micro sample injector (25ul, Hamilton company)
GL-20G-Ⅱ冷冻离心机(上海安亭科学仪器厂)GL-20G-Ⅱ refrigerated centrifuge (Shanghai Anting Scientific Instrument Factory)
ZZ-6小鼠自主活动测试仪(成都泰盟科技有限公司)ZZ-6 mouse autonomous activity tester (Chengdu Taimeng Technology Co., Ltd.)
Boston Green ODS C18柱(4.6×250mm,5μm,)Boston Green ODS C18 column (4.6×250mm, 5μm, )
1.3实验场地及动物合格证号1.3 Experiment site and animal certificate number
成都中医药大学国家中医药管理局三级中药药理实验室,证书登记编号:TCM-2009-135。实验动物合格证书:SCXK(川)2009-11。Chengdu University of Traditional Chinese Medicine State Administration of Traditional Chinese Medicine Class III Pharmacology Laboratory of Traditional Chinese Medicine, certificate registration number: TCM-2009-135. Laboratory animal certificate: SCXK (Sichuan) 2009-11.
2实验统计软件及方法2 Experimental statistical software and methods
通过SPSS13.0统计软件进行单因素方差分析及卡方检验。One-way analysis of variance and chi-square test were carried out by SPSS13.0 statistical software.
3实验方法及结果3 Experimental methods and results
3.1基于正交试验对厚朴汁炙远志药液的条件设计3.1 Conditional design of Magnolia officinalis Juice Sunburn Polygala medicinal liquid based on orthogonal experiment
采用7因素3水平正交试验表,选取A(远志厚朴比例)、B(厚朴煎汁时间)、C(厚朴汁浓缩体积)、D(炒炙温度)、E(炒炙时间)、F(炙远志煎煮时间)6个因素,拟定出18组不同炮制药液的工艺。Using 7 factors and 3 levels of orthogonal test table, select A (proportion of Polygala officinalis Magnolia officinalis), B (time for decocting Magnolia officinalis), C (concentrated volume of Magnolia officinalis juice), D (stir frying temperature), E (stir frying time) , F (Polygalus decocting time) 6 factors, draw up 18 groups of different processes for concocting liquid medicine.
厚朴汁炙远志炮制药液的工艺如下:厚朴药材A(n*50)g→浸泡30min→武火煮沸,文火煎煮Bmin→减压浓缩至Cml,制成厚朴药汁→将厚朴药汁加入50g远志生药材中,闷润3h→D摄氏度炒远志Emin→将炒好远志摊开、晾干→10倍水浸泡远志炮制品30min→武火煮沸,文火煎煮Fmin→减压浓缩至50ml→定容至100ml→炮制药液含生药材量0.5g/ml。因素、水平数如下表1所示,实验安排如表2所示。The process of making Magnolia officinalis Zhigala medicinal liquid is as follows: Magnolia officinalis medicinal material A (n*50) g→soaked for 30 minutes→boiled with strong fire, decocted at slow fire for Bmin→concentrated to Cml under reduced pressure to make Magnolia officinalis juice→make Magnolia officinalis Add the medicinal juice to 50g Polygala raw medicinal materials, moisten it for 3 hours→stir-fry Polygala Emin at D degree Celsius→spread out the fried Polygala and dry it→soak Polygala processed product in 10 times of water for 30min→boil with strong fire, decoct with slow fire Fmin→concentrate under reduced pressure to 50ml→constant volume to 100ml→concoct the medicinal solution containing 0.5g/ml raw medicinal materials. The factors and levels are shown in Table 1 below, and the experimental arrangement is shown in Table 2.
表16因素3水平表Table 16 Factor 3 level table
表2实验安排表Table 2 Experiment Arrangement
3.2基于胃残留率与肠推进实验优选缓解胃肠动力障碍的炮制品3.2 Based on the gastric residual rate and intestinal propulsion test, the processed products for alleviating gastrointestinal motility disorders are selected
3.2.1药液的制备3.2.1 Preparation of liquid medicine
远志药液:10倍水浸泡50g远志生药材30min→武火煮沸,文火煎煮60min→减压浓缩至50ml→定容至100ml→炮制药液含生药材量0.5g/ml。Polygala medicinal liquid: Soak 50g Polygala raw medicinal materials in 10 times of water for 30 minutes→boil with strong fire, decoct with slow fire for 60min→concentrate under reduced pressure to 50ml→concentrate to 100ml→process the medicinal solution containing 0.5g/ml of raw medicinal materials.
厚朴药液:10倍水浸泡50g厚朴生药材30min→武火煮沸,文火煎煮15min→减压浓缩至50ml→定容至100ml→炮制药液含生药材量0.5g/ml。Magnolia officinalis medicinal liquid: Soak 50g of magnolia officinalis in 10 times of water for 30 minutes→boil with strong fire, decoct in slow fire for 15min→concentrate under reduced pressure to 50ml→concentrate to 100ml→concoct the liquid containing 0.5g/ml of raw medicinal materials.
配伍药液:10倍水浸泡50g远志生药材30min→武火煮沸,文火煎煮45min→加入10倍量水浸泡30min的生厚朴药材100g→武火煮沸,文火煎煮15min→减压浓缩至50ml→定容至100ml→炮制药液含生药材量1.5g/ml。Compatible medicinal liquid: Soak 50g Polygala officinalis in 10 times of water for 30min→boil with strong fire, decoct with slow fire for 45min→add 100g of raw Magnolia officinalis medicinal material soaked in 10 times of water for 30min→boil with strong fire, decoct with slow fire for 15min→concentrate to 50ml under reduced pressure→ Set the volume to 100ml → concoct the medicinal solution containing 1.5g/ml of crude drug.
厚朴汁炙远志的药液:制备如3.1法进行制备炮制品1-18组。Magnolia officinalis Zhizhi medicinal liquid: preparation as in 3.1 to prepare groups of processed products 1-18.
3.2.2胃排空与小肠推进实验方法3.2.2 Experimental method of gastric emptying and small intestine propulsion
取健康昆明种小鼠300只,雌雄各半,体重18-22g。按性别体重随机分为空白组、远志组、厚朴组、配伍组、炮制1组、炮制2组、3、4、5、6……18组,每组10只(分组与给药剂量详见于表3-7)。实验前禁食不禁水24h,每组按0.2ml/10g灌胃给予相应药液,空白组给予同体积生理盐水。给药40min后,灌胃给予小鼠营养性半固体糊(10g CMC-Na,250ml生理盐水,奶粉16g,糖8g,淀粉8g,活性炭末2g,搅拌均匀,配制成300ml,约300g的黑色半固体糊状物。冰箱冷藏,用时恢复至室温。)0.4ml/10g,20min后脱颈处死。Take 300 healthy Kunming mice, half male and half male, weighing 18-22 g. According to sex and body weight, they were randomly divided into blank group, Polygala group, Magnolia officinalis group, compatibility group, processed 1 group, processed 2 group, 3, 4, 5, 6... 18 groups, 10 animals in each group (details for grouping and dosage) See Table 3-7). Before the experiment, fasting without food and water for 24 hours, each group was given the corresponding medicinal solution by intragastric administration of 0.2ml/10g, and the blank group was given the same volume of normal saline. After 40 minutes of administration, the mice were given nutritional semi-solid paste (10g CMC-Na, 250ml normal saline, 16g milk powder, 8g sugar, 8g starch, 2g activated carbon powder, stirred evenly, and prepared into 300ml, about 300g black semi-solid paste) Solid paste. Refrigerate in the refrigerator, return to room temperature when used.) 0.4ml/10g, 20min later, kill by neck dislocation.
解剖小鼠腹腔,结扎胃贲门和幽门,取胃,用滤纸拭干后称全重,然后沿胃大弯剪开胃体,洗去胃内容物后拭干,称净重,计算胃残留率(%)。The abdominal cavity of the mouse was dissected, the gastric cardia and pylorus were ligated, the stomach was taken out, dried with filter paper and weighed, then the gastric body was cut along the greater curvature of the stomach, the contents of the stomach were washed away and dried, and the net weight was calculated to calculate the gastric residual rate (% ).
胃残留率(%)=[(胃全重-胃净重)/炭糊重]×100%Stomach residual rate (%)=[(whole stomach weight - net stomach weight)/charcoal paste weight]×100%
解剖小鼠腹腔,剪取胃部幽门至回盲部。用镊子不加牵引地取出整个小肠段,铺直于表面湿润的板子上,测量幽门至炭糊最前端的距离和幽门至回盲部全长,计算小肠推进率。The abdominal cavity of the mouse was dissected, and the pylorus from the stomach to the ileocecal was cut. The entire small intestine was taken out with tweezers without traction, laid straight on a board with a wet surface, the distance from the pylorus to the front of the charcoal paste and the total length from the pylorus to the ileocecal were measured, and the propulsion rate of the small intestine was calculated.
小肠推进率(%)=(炭糊移动距离/幽盲全长)×100%Small intestine propulsion rate (%) = (moving distance of charcoal paste/full length of pluvialis) × 100%
所得结果用单因素方差分析进行统计。The obtained results were statistically analyzed by one-way analysis of variance.
3.2.3实验结果3.2.3 Experimental results
结果如表3~表7所示。The results are shown in Table 3~Table 7.
表3厚朴汁炙远志对小鼠胃残留率及肠推进率的影响(1) Table 3 Effects of Sunburning Polygala Magnolia Juice on Gastric Residue Rate and Intestinal Propulsion Rate in Mice (1)
注:与空白组比较,*P<0.05;与远志组比较,△P<0.05Note: Compared with blank group, *P<0.05; compared with Polygala group, △P<0.05
表4厚朴汁炙远志对小鼠胃残留率及肠推进率的影响(2) Table 4 The effect of stewed Polygala magnolia juice on gastric residual rate and intestinal propulsion rate in mice (2)
注:与厚朴组比较,*P<0.05,**P<0.01;与远志组比较,△P<0.05,△△P<0.01Note: Compared with Magnolia officinalis group, *P<0.05, **P<0.01; compared with Polygala group, △P<0.05, △△P<0.01
表5厚朴汁炙远志对小鼠胃残留率及肠推进率的影响(3) Table 5 The effect of stewed polygala with Magnolia officinalis juice on gastric residual rate and intestinal propulsion rate in mice (3)
注:与厚朴组比较,*P<0.05,**P<0.01;与远志组比较,△P<0.05,△△P<0.01Note: Compared with Magnolia officinalis group, *P<0.05, **P<0.01; compared with Polygala group, △P<0.05, △△P<0.01
表6厚朴汁炙远志对小鼠胃残留率及肠推进率的影响(4) Table 6 The effect of stewed polygala with Magnolia officinalis juice on gastric residual rate and intestinal propulsion rate in mice (4)
注:与厚朴组比较,**P<0.01;与远志组比较,△P<0.05,△△P<0.01Note: Compared with Magnolia officinalis group, **P<0.01; compared with Polygala group, △P<0.05, △△P<0.01
表7厚朴汁炙远志对小鼠胃残留率及肠推进率的影响(5) Table 7 The effect of stewed polygala with Magnolia officinalis juice on gastric residual rate and intestinal propulsion rate in mice (5)
注:与厚朴组比较,*P<0.05;与远志组比较,△P<0.05Note: Compared with Magnolia officinalis group, *P<0.05; compared with Polygala group, △P<0.05
结果显示,炮制品5组与炮制品12组能明显缓解远志所致的胃肠动力抑制。故选取此两种厚朴汁炙远志炮制品进行重复性实验及相关药效学考察。The results showed that the processed product group 5 and the processed product group 12 could significantly alleviate the inhibition of gastrointestinal motility caused by polygala. Therefore, these two processed products of Magnolia officinalis Juice and Radix Polygala were selected for repeated experiments and related pharmacodynamic investigations.
3.3优选炮制品对胃肠动力影响的重复性实验3.3 Repeated experiments on the influence of optimized processed products on gastrointestinal motility
3.3.1.1药液的制备3.3.1.1 Preparation of liquid medicine
远志20分钟药液:10倍水浸泡50g远志生药材30min→武火煮沸,文火煎煮20min→减压浓缩至50ml→定容至100ml→炮制药液含生药材量0.5g/ml。Polygala medicinal liquid for 20 minutes: Soak 50g Polygala raw medicinal materials in 10 times of water for 30 minutes→boil with strong fire, decoct with slow fire for 20min→concentrate under reduced pressure to 50ml→concentrate to 100ml→process the medicinal solution containing 0.5g/ml of raw medicinal materials.
厚朴10分钟药液:10倍水浸泡50g厚朴生药材30min→武火煮沸,文火煎煮10min→减压浓缩至50ml→定容至100ml→炮制药液含生药材量0.5g/ml。Magnolia officinalis medicinal liquid for 10 minutes: Soak 50g of magnolia bark raw medicinal materials in 10 times of water for 30 minutes → boil with strong fire, decoct with slow fire for 10 minutes → concentrate under reduced pressure to 50ml → dilute to 100ml → concoct the medicinal liquid containing 0.5g/ml of raw medicinal materials.
厚朴汁炙远志药液5:厚朴药材100g→浸泡30min→武火煮沸,文火煎煮10min→减压浓缩至25ml,制成厚朴药汁→将厚朴药汁加入50g远志生药材中,闷润3h→120摄氏度炒远志12min→将炒好远志摊开、晾干→10倍水浸泡远志炮制品30min→武火煮沸,文火煎煮20min→减压浓缩至50ml→定容至100ml。Magnolia Juice Radix Polygala Medicinal Solution 5: Magnolia officinalis medicinal material 100g→soak for 30min→boil with strong fire, decoct with slow fire for 10min→concentrate to 25ml under reduced pressure to make magnolia medicinal juice→add magnolia medicinal juice to 50g Polygala medicinal material, Moisturize for 3 hours→stir-fry Polygala at 120 degrees Celsius for 12 minutes→spread out the fried Polygala and dry it→soak the processed Polygala in 10 times of water for 30min→boil with strong fire and simmer for 20min→concentrate under reduced pressure to 50ml→concentrate to 100ml.
厚朴汁炙远志药液12:厚朴药材50g→浸泡30min→武火煮沸,文火煎煮15min→减压浓缩至25ml,制成厚朴药汁→将厚朴药汁加入50g远志生药材中,闷润3h→90摄氏度炒远志6min→将炒好远志摊开、晾干→10倍水浸泡远志炮制品30min→武火煮沸,文火煎煮20min→减压浓缩至50ml→定容至100ml。Magnolia Juice Radix Polygalis Medicinal Solution 12: 50g of Magnolia officinalis → soak for 30 minutes → boil with strong fire, decoct with slow fire for 15 minutes → reduce pressure and concentrate to 25ml to make Magnolia officinalis juice → add Magnolia officinalis to 50g of Polygala, Moisturize for 3 hours→stir-fry Polygala at 90 degrees Celsius for 6 minutes→spread out the fried Polygala and dry it→soak the processed Polygala in 10 times water for 30min→boil with strong fire, decoct for 20min on low heat→concentrate under reduced pressure to 50ml→concentrate to 100ml.
3.3.1.2实验方法3.3.1.2 Experimental method
取健康昆明种小鼠84只,雌雄各半,体重18-22g。按小鼠性别体重随机分为空白组、西沙必利组、远志20分钟组、厚朴10分钟组、炮制品5组、炮制品12组,每组14只。按照3.2.2胃残留、肠推进实验方法进行实验。Take 84 healthy Kunming mice, half male and half male, weighing 18-22 g. The mice were randomly divided into blank group, cisapride group, Polygala 20-minute group, Magnolia officinalis 10-minute group, processed 5 groups, and processed 12 groups according to sex and body weight, with 14 mice in each group. According to 3.2.2 gastric residual, intestinal propulsion test method to carry out the experiment.
3.3.1.3实验结果如表8所示。3.3.1.3 The experimental results are shown in Table 8.
表8厚朴汁炙远志对小鼠胃残留及肠推进影响的重复实验 Table 8 Repeated experiments on the effect of magnolia bark juice on Polygalaceae polygala on gastric residue and intestinal propulsion in mice
注:与空白组比较**P<0.01,*P<0.05;与远志组比较,△△P<0.01,△P<0.05Note: Compared with blank group, **P<0.01, *P<0.05; compared with Polygala group, △△P<0.01, △P<0.05
结果显示,炮制品5组与炮制品12组均能显著降低小鼠胃残留率及增加小肠推进率(P<0.05),但炮制品12组的胃残留率显著高于空白组(P<0.05),提示该炮制品依然会影响胃运动;而炮制品5与空白组无显著性差异(P>0.05),说明炮制5组更接近正常小鼠。此外,另在戊巴比妥钠协同试验中,炮制品12组并未呈现出安神药效,故其后的药效学实验只选择炮制品5进行研究。The results showed that both the processed product 5 group and the processed product 12 group could significantly reduce the gastric residual rate and increase the small intestinal propulsion rate (P<0.05), but the gastric residual rate of the processed product 12 group was significantly higher than that of the blank group (P<0.05 ), suggesting that the processed product still affects gastric motility; while the processed product 5 has no significant difference with the blank group (P>0.05), indicating that the processed 5 group is closer to normal mice. In addition, in the pentobarbital sodium synergistic test, the processed product 12 did not show the effect of calming the nerves, so only the processed product 5 was selected for the subsequent pharmacodynamic experiments.
3.3.2.1药液的制备3.3.2.1 Preparation of liquid medicine
①远志药液:10倍水浸泡50g远志生药材30min→武火煮沸,文火煎煮20min→减压浓缩至50ml→定容至100ml→药液含生药材量0.5g/ml。①Polygalae medicinal liquid: Soak 50g Polygala raw medicinal materials in 10 times of water for 30 minutes→boil with strong fire, decoct with slow fire for 20min→concentrate under reduced pressure to 50ml→concentrate to 100ml→the medicinal solution contains 0.5g/ml of raw medicinal materials.
②厚朴药液:10倍水浸泡100g厚朴生药材30min→武火煮沸,文火煎煮10min→减压浓缩至50ml→定容至100ml→药液含生药材量1.0g/ml。② Magnolia officinalis medicinal liquid: Soak 100g of magnolia officinalis in 10 times of water for 30 minutes→boil with strong fire, decoct in slow fire for 10min→concentrate under reduced pressure to 50ml→concentrate to 100ml→the liquid contains 1.0g/ml of raw medicinal materials.
③厚朴汁炙远志药液高剂量:厚朴药材100g→浸泡30min→武火煮沸,文火煎煮10min→减压浓缩至25ml,制成厚朴药汁→将厚朴药汁加入50g远志生药材中,闷润3h→120摄氏度炒远志12min→将炒好远志摊开、晾干→10倍水浸泡远志炮制品30min→武火煮沸,文火煎煮20min→减压浓缩至50ml→定容至100ml→药液含生药材量1.5g/ml。③High dosage of Magnolia officinalis Zhizhi medicinal liquid: Magnolia officinalis medicinal material 100g→soak for 30min→boil with strong fire, decoct on slow fire for 10min→concentrate to 25ml under reduced pressure to make Magnolia officinalis medicinal juice→add Magnolia bark medicinal juice to 50g Polygala medicinal material Medium, moisten for 3 hours→stir-fry polygala at 120 degrees Celsius for 12 minutes→spread out the fried polygala and dry it→soak the processed polygala in 10 times of water for 30 minutes→boil with strong fire and simmer for 20 minutes→concentrate under reduced pressure to 50ml→concentrate to 100ml→ The medicinal liquid contains 1.5g/ml of raw medicinal materials.
④配伍药液:10倍水浸泡50g远志生药材30min→武火煮沸,文火煎煮10min→加入10倍水浸泡100g厚朴生药材30min的厚朴→武火煮沸,文火煎煮10min→减压浓缩至50ml→定容至100ml→药液含生药材量1.5g/ml。④Compatible medicinal liquid: Soak 50g Polygala officinalis in 10 times of water for 30min→boil with strong fire, decoct with slow fire for 10min→add Magnolia officinalis and soak 100g of Magnolia officinalis in 10 times of water for 30min→boil with strong fire, decoct with slow fire for 10min→concentrate under reduced pressure to 50ml → dilute to 100ml → the liquid contains 1.5g/ml raw medicinal materials.
3.3.2.2实验方法3.3.2.2 Experimental method
取健康昆明种小鼠84只,雌雄各半,体重18-22g。按性别体重随机分为空白组、西沙必利组、远志组、厚朴组、配伍组、炮制高剂量组,每组14只。实验前禁食不禁水24h,每组按0.2ml/10g灌胃给予相应药液,空白组给予同体积生理盐水。给药40min后,灌胃给予小鼠营养性半固体糊(10g CMC-Na,250ml生理盐水,奶粉16g,糖8g,淀粉8g,活性炭末2g,搅拌均匀,配制成300ml,约300g的黑色半固体糊状物。冰箱冷藏,用时恢复至室温。)0.4ml/10g,20min后脱颈处死。Take 84 healthy Kunming mice, half male and half male, weighing 18-22 g. They were randomly divided into blank group, cisapride group, Polygala group, Magnolia officinalis group, compatibility group and processed high-dose group according to sex and body weight, with 14 rats in each group. Before the experiment, fasting without food and water for 24 hours, each group was given the corresponding medicinal solution by intragastric administration of 0.2ml/10g, and the blank group was given the same volume of normal saline. After 40 minutes of administration, the mice were given nutritional semi-solid paste (10g CMC-Na, 250ml normal saline, 16g milk powder, 8g sugar, 8g starch, 2g activated carbon powder, stirred evenly, and prepared into 300ml, about 300g black semi-solid paste) Solid paste. Refrigerate in the refrigerator, return to room temperature when used.) 0.4ml/10g, 20min later, kill by neck dislocation.
解剖小鼠腹腔,结扎胃贲门和幽门,取胃,用滤纸拭干后称全重,然后沿胃大弯剪开胃体,洗去胃内容物后拭干,称净重,计算胃残留率(%)。The abdominal cavity of the mouse was dissected, the gastric cardia and pylorus were ligated, the stomach was taken out, dried with filter paper and weighed, then the gastric body was cut along the greater curvature of the stomach, the contents of the stomach were washed away and dried, and the net weight was calculated to calculate the gastric residual rate (% ).
胃残留率(%)=[(胃全重-胃净重)/炭糊重]×100%Stomach residual rate (%)=[(whole stomach weight - net stomach weight)/charcoal paste weight]×100%
解剖小鼠腹腔,剪取胃部幽门至回盲部。用镊子不加牵引地取出整个小肠段,铺直于表面湿润的板子上,测量幽门至炭糊最前端的距离和幽门至回盲部全长,计算小肠推进率。The abdominal cavity of the mouse was dissected, and the pylorus from the stomach to the ileocecal was cut. The entire small intestine was taken out with tweezers without traction, laid straight on a board with a wet surface, the distance from the pylorus to the front of the charcoal paste and the total length from the pylorus to the ileocecal were measured, and the propulsion rate of the small intestine was calculated.
小肠推进率(%)=(炭糊移动距离/幽盲全长)×100%Small intestine propulsion rate (%) = (moving distance of charcoal paste/full length of pluvialis) × 100%
3.3.2.3实验结果如表9所示。3.3.2.3 The experimental results are shown in Table 9.
表9厚朴汁炙远志对小鼠胃残留及肠推进影响实验结果 Table 9 Experimental results of Sunburning Polygala Magnolia Juice on Stomach Residue and Intestinal Propulsion in Mice
与远志组比较,△△P<0.01,△P<0.05Compared with Polygala group, △△P<0.01, △P<0.05
结果显示,与远志组比较,空白组、西沙必利组、厚朴组、配伍组及炮制高剂量组均能显著降低小鼠胃残留率(△△P<0.01,△P<0.05);空白组、西沙必利组、厚朴组及炮制品高剂量组均能显著增加小鼠肠推进率(△△P<0.01,△P<0.05)。说明炮制品高剂量组能显著缓解远志造成的胃肠动力障碍,且效果优于平行制备的配伍组。The results showed that compared with Polygala group, blank group, cisapride group, Magnolia officinalis group, compatibility group and processed high-dose group could significantly reduce the gastric residual rate of mice (△△P<0.01, △P<0.05); group, cisapride group, magnolia bark group and processed high-dose group can significantly increase the intestinal propulsion rate of mice (△△P<0.01, △P<0.05). It shows that the processed high-dose group can significantly alleviate the gastrointestinal motility disorder caused by polygala, and the effect is better than that of the parallel-prepared compatibility group.
3.4炮制品戊巴比妥钠协同催眠及镇咳药效学研究3.4 Study on pharmacodynamics of processed pentobarbital sodium in synergy with hypnosis and antitussive
①远志药液:10倍水浸泡50g远志生药材30min→武火煮沸,文火煎煮20min→减压浓缩至50mL→定容至100mL,浓缩为含生药材浓度为0.5g/mL的药液。①Polygalae medicinal liquid: Soak 50g Polygala raw medicinal materials in 10 times of water for 30 minutes→boil with strong fire, decoct with slow fire for 20min→concentrate under reduced pressure to 50mL→concentrate to 100mL, concentrate to a medicinal solution containing raw medicinal materials at a concentration of 0.5g/mL.
②厚朴药液:10倍水浸泡100g厚朴生药材30min→武火煮沸,文火煎煮10min→减压浓缩至50mL→定容至100mL,浓缩为含生药材浓度为1.0g/mL的药液。②Magnolia officinalis medicinal liquid: Soak 100g of magnolia officinalis in 10 times of water for 30 minutes→boil with strong fire, decoct in slow fire for 10min→concentrate under reduced pressure to 50mL→concentrate to 100mL, concentrate to a medicinal solution containing raw medicinal materials at a concentration of 1.0g/mL .
③炮制品高剂量药液:厚朴药材100g→浸泡30min→武火煮沸,文火煎煮10min→减压浓缩至25ml,制成厚朴药汁→将厚朴药汁加入50g远志生药材中,闷润3h→120摄氏度炒远志12min→将炒好远志摊开、晾干→10倍水浸泡远志炮制品30min→武火煮沸,文火煎煮20min→减压浓缩至50ml→定容至100ml,浓缩为含生药材浓度为1.5g/mL的药液。③ High-dose medicinal liquid for processed products: Magnolia officinalis medicinal material 100g→soak for 30min→boil with strong fire, decoct with slow fire for 10min→concentrate to 25ml under reduced pressure to make magnolia officinalis medicinal juice→add magnolia Wet for 3 hours→Stir-fry Polygala at 120 degrees Celsius for 12min→Spread out the fried Polygala and dry it→Soak the processed Polygala in 10 times of water for 30min→Boil with strong fire, decoct with slow fire for 20min→Concentrate under reduced pressure to 50ml→Concentrate to 100ml, concentrate to contain The medicinal liquid with the concentration of raw medicinal materials is 1.5g/mL.
④炮制品中剂量药液:取高剂量药液50ml,定容至100ml。④Medium-dose medicinal liquid for processed products: Take 50ml of high-dose medicinal liquid and dilute to 100ml.
⑤炮制品低剂量药液:取中剂量药液50ml,定容至100ml。⑤ Low-dose medicinal liquid for processed products: Take 50ml of medium-dose medicinal liquid and dilute to 100ml.
3.4.1对戊巴比妥钠协同催眠小鼠的实验方法及结果3.4.1 Experimental method and results of pentobarbital sodium synergistically hypnotizing mice
取健康昆明种小鼠98只,按性别体重随机分为空白组、地西泮组、远志组、厚朴组、炮制品高剂量组、炮制品中剂量组及炮制品低剂量组共7组,每组14只。实验前禁食不禁水9h,按照0.2mL/10g灌胃给予相应药液,空白组给予同体积的生理盐水。给药30min后,腹腔注射新鲜配制的30mg/kg的戊巴比妥钠溶液(150mg配成100mL)。以小鼠翻正反射消失1min以上为入睡标准。统计各组15min内小鼠入睡百分率。结果如表10所示。98 healthy Kunming mice were randomly divided into 7 groups according to sex and body weight: blank group, diazepam group, Polygala group, Magnolia officinalis group, processed high-dose group, processed medium-dose group and processed low-dose group , 14 in each group. Before the experiment, fasting without food and water for 9 hours, 0.2mL/10g orally administered the corresponding medicinal solution, and the blank group was given the same volume of normal saline. After 30 minutes of administration, freshly prepared 30 mg/kg pentobarbital sodium solution (150 mg to 100 mL) was intraperitoneally injected. The righting reflex of the mice disappeared for more than 1 min as the standard for falling asleep. The percentage of mice falling asleep within 15 min in each group was counted. The results are shown in Table 10.
表10不同剂量厚朴汁炙远志对戊巴比妥钠协同小鼠催眠作用的影响Table 10 The effect of different doses of Magnolia officinalis Juice Sunburn Polygala on the hypnotic effect of pentobarbital sodium in synergistic mice
与空白组比较,*P<0.05,**P<0.01Compared with blank group, *P<0.05, **P<0.01
结果显示,与空白组比较,地西泮组、炮制品高剂量组、炮制品中剂量组能显著增强对戊巴比妥钠协同小鼠催眠的作用(P<0.05)。The results showed that, compared with the blank group, the diazepam group, the processed product high-dose group, and the processed product medium-dose group could significantly enhance the hypnotic effect of pentobarbital sodium on mice (P<0.05).
3.4.2对氨水所致小鼠咳嗽的镇咳作用实验方法及结果3.4.2 Experimental method and results of antitussive effect on mice cough induced by ammonia water
取健康昆明种小鼠98只,按体重随机分为空白组、复方甘草片组、远志组、厚朴组、炮制品高剂量组、炮制品中剂量组及炮制品低剂量组共5组,每组14只。实验前禁食不禁水9h,按照20mL/kg灌胃给予相应药液,空白组给予同体积的生理盐水。给药1h后,将小鼠置于容积为250mL的广口瓶中,其内放一棉球,用移液枪每次吸25%~28%氨水0.1mL注入棉球上。咳嗽的表现为小鼠腹肌收缩,同时张大嘴,有时有咳声。观察并记录小鼠3min内的起始咳嗽时间及咳嗽次数。结果如表11所示。98 healthy Kunming mice were randomly divided into 5 groups according to body weight: blank group, compound licorice tablet group, Polygala group, Magnolia officinalis group, processed high-dose group, processed medium-dose group and processed low-dose group. 14 in each group. Before the experiment, fasting without food and water for 9 hours, the corresponding medicinal solution was given by intragastric administration at 20 mL/kg, and the blank group was given the same volume of normal saline. One hour after the administration, the mice were placed in a 250-mL jar with a cotton ball in it, and 0.1 mL of 25% to 28% ammonia water was sucked into the cotton ball with a pipette gun each time. Coughing is manifested by the contraction of the abdominal muscles of the mouse and the opening of the mouth at the same time, sometimes with a coughing sound. Observe and record the initial coughing time and coughing times of the mice within 3 min. The results are shown in Table 11.
表11不同剂量厚朴汁炙远志对氨水所致小鼠咳嗽的镇咳作用的影响 Table 11 The antitussive effect of different doses of Magnolia officinalis Juice Sunburn Polygala on ammonia water-induced cough in mice
结果显示,与空白组比较,各给药组均能极显著地降低氨水所致小鼠的咳嗽次数(P<0.01);复方甘草片组、炮制品高剂量组还能极显著延长氨水所致小鼠咳嗽潜伏时间(P<0.01),远志组、厚朴组能显著延长氨水所致小鼠咳嗽的潜伏期(P<0.05)。The results showed that, compared with the blank group, each administration group could significantly reduce the cough frequency of mice induced by ammonia water (P<0.01); Cough latency of mice (P<0.01), Polygala group and Magnolia officinalis group can significantly prolong the latency of cough induced by ammonia water (P<0.05).
3.5不同剂量对小鼠祛痰作用及自主活动的影响3.5 Effects of different doses on expectorant effect and autonomous activity in mice
3.5.1不同剂量对小鼠祛痰作用的影响3.5.1 Effect of different doses on expectorant effect in mice
(1)1%酚红的制备(1) Preparation of 1% phenol red
1%酚红的配制:将1g酚红溶于11.28ml的浓度为0.04g/100ml的NaOH生理盐水溶液中,将酚红研磨至无细小颗粒后,漏斗过滤,用生理盐水重复洗漱漏斗,将其定容至100ml容量瓶中,即得。Preparation of 1% phenol red: Dissolve 1 g of phenol red in 11.28 ml of NaOH saline solution with a concentration of 0.04 g/100 ml, grind the phenol red until there are no fine particles, filter through the funnel, wash the funnel repeatedly with normal saline, and put Dilute it to a 100ml volumetric flask, and get ready.
(2)实验方法与结果(2) Experimental methods and results
取健康昆明种小鼠112只,禁食不禁水9h,按体重随机分为空白组、厚朴干扰对照组、氯化铵组、远志组、厚朴组、炮制品高剂量组、炮制品中剂量组及炮制品低剂量组,共8组,每组14只。按20mL/kg灌胃给药小鼠相应药液,空白组给予相同体积的生理盐水。给药30min后,除厚朴干扰对照组按10mL/kg腹腔注射生理盐水外,其余7组按10mL/kg体重腹腔注射1%酚红,30min后处死小鼠,剥去气管周围组织,剪下自甲状软骨下至气管分支处的一段气管,放进盛有2mL生理盐水的试管中,再加入0.1mL氢氧化钠溶液(1mol/L),震荡10min,3000rpm离心15min,取上清液加入96孔板,用酶标仪进行测定,波长546nm,测定吸光度(OD)值。112 healthy Kunming mice were fasted for 9 hours, and randomly divided into blank group, Magnolia officinalis interference control group, ammonium chloride group, Polygala group, Magnolia officinalis group, processed high-dose group, and processed medium group according to body weight. Dose group and processed product low-dose group, a total of 8 groups, 14 rats in each group. Mice were given the corresponding drug solution by intragastric administration at 20 mL/kg, and the blank group was given the same volume of normal saline. After 30 minutes of administration, except the magnolia bark interference control group was injected with 10 mL/kg of normal saline intraperitoneally, the other 7 groups were injected with 1% phenol red at 10 mL/kg of body weight, and the mice were sacrificed 30 minutes later, the tissues around the trachea were peeled off, and cut out A section of the trachea from the thyroid cartilage to the branch of the trachea was put into a test tube containing 2 mL of normal saline, and then 0.1 mL of sodium hydroxide solution (1mol/L) was added, shaken for 10 min, centrifuged at 3000 rpm for 15 min, and the supernatant was added to 96 Orifice plates were measured with a microplate reader at a wavelength of 546 nm to measure the absorbance (OD) value.
为排除厚朴酚对酚红实验干扰,专设厚朴干扰对照组,以排除厚朴酚对特定波长吸光度的干扰。实验步骤为:按20ml/kg灌胃给药小鼠相应厚朴药液,给药30min后,按0.1ml/10g体重腹腔注射生理盐水,30min处死小鼠,步骤同上进行测定。所得结果用单因素方差分析进行统计。结果如表12所示。In order to exclude the interference of magnolol on the phenol red experiment, a magnolol interference control group was specially set up to exclude the interference of magnolol on the absorbance of specific wavelengths. The experimental procedure is as follows: intragastric administration of 20ml/kg of the corresponding magnolia bark liquid to mice, 30min after administration, intraperitoneal injection of normal saline at 0.1ml/10g of body weight, 30min to kill the mice, and the procedure is the same as above for determination. The obtained results were statistically analyzed by one-way analysis of variance. The results are shown in Table 12.
表12不同剂量厚朴汁炙远志对小鼠酚红排泌作用的影响 Table 12 Effects of different doses of Magnolia officinalis Juice Sunburned Polygala on the Excretion of Phenol Red in Mice
结果显示,厚朴干扰对照组的OD值与空白组比较无显著性差异(P>0.05),且其OD值低于空白组。与空白组比较,氯化铵组与炮制品高剂量组均能显著增加气管内酚红的OD值(P<0.05,P<0.01),远志组及厚朴组均有高于空白组OD值的趋势,但均无显著性差异(P>0.05)。The results showed that the OD value of the Magnolia officinalis interference control group was not significantly different from that of the blank group (P>0.05), and its OD value was lower than that of the blank group. Compared with the blank group, both the ammonium chloride group and the high-dose processed product group could significantly increase the OD value of phenol red in the trachea (P<0.05, P<0.01), and the polygala group and Magnolia officinalis group had higher OD values than the blank group. trend, but there was no significant difference (P>0.05).
3.5.2不同剂量对小鼠自主活动的影响3.5.2 Effects of Different Doses on Autonomous Activities of Mice
取健康昆明种小鼠98只。适应性饲养3d,并每天固定在13:00将小鼠分别放置于小鼠自主活动测定仪3min后,分别记录小鼠5min活动值,活动值为活动次数与站立次数的总和。淘汰过于活跃或者很不活跃的小鼠,筛选出平均活动值在80~200之间的作为合格小鼠。于实验第4d,再次测定并记录小鼠活动值作为给药前的基础活动值,并按照基础活动值随机平行地将小鼠分为空白组,地西泮组、远志组、厚朴组、炮制品高剂量组、炮制品中剂量组及炮制品低剂量组共7组,每组14只。分组后第2d即正式实验第1d,各给药组按20mL/kg灌胃给予小鼠相应药液,空白组给予相同体积生理盐水,连续7d。于正式实验第1d、3d、7d给药30min,同法测定小鼠活动次数与站立次数,作为小鼠给药后活动值。Take 98 healthy Kunming mice. Adaptive feeding for 3 days, and fixed at 13:00 every day, the mice were placed in the mouse autonomous activity measuring instrument for 3 minutes, and the activity value of the mouse was recorded for 5 minutes, and the activity value was the sum of the number of activities and the number of standing. Mice that were too active or very inactive were eliminated, and those with an average activity value between 80 and 200 were selected as qualified mice. On the 4th day of the experiment, the activity value of the mice was measured and recorded again as the basic activity value before administration, and the mice were randomly divided into blank groups, diazepam group, polygala group, magnolia bark group, There were 7 groups including high-dose processed product group, medium-dose processed product group and low-dose processed product group, with 14 rats in each group. On the 2nd day after the grouping, which is the 1st day of the formal experiment, each drug group was given the corresponding drug solution by intragastric administration at 20 mL/kg, and the blank group was given the same volume of normal saline for 7 consecutive days. On the 1st, 3d, and 7th days of the formal experiment, the mice were administered for 30 minutes, and the number of activities and standing times of the mice were measured in the same way as the activity values of the mice after administration.
以活动抑制率反映小鼠自主活动的变化。The activity inhibition rate was used to reflect the change of the autonomous activity of the mice.
活动抑制率=〔(给药后的活动值-活动基础值)/活动基础值〕×100%Activity inhibition rate = [(activity value after administration - activity base value) / activity base value] × 100%
所得结果用sas8.0进行Kruskal分析。实验结果如表13所示。The obtained results were analyzed by Kruskal using sas8.0. The experimental results are shown in Table 13.
表13不同剂量厚朴汁炙远志对小鼠自主活动变化作用的影响 Table 13 The effect of different doses of Magnolia officinalis Juice Sunburn Polygala on the change of autonomic activity in mice
结果显示,给药前各组件无显著性差异(P>0.05)。给药后,与空白组比较,地西泮组、炮制高剂量组在1d、3d、7d时间里均能显著抑制小鼠自主活动(P<0.05,P<0.01),炮制品中剂量组在1d、3d及远志组在3d能显著抑制小鼠自主活动(P<0.05)呈现出镇静作用。The results showed that there was no significant difference among the components before administration (P>0.05). After administration, compared with the blank group, the diazepam group and the processed high-dose group could significantly inhibit the spontaneous activity of the mice in 1d, 3d, and 7d (P<0.05, P<0.01), and the processed medium-dose group was at 1d, 3d and polygala group can significantly inhibit the autonomous activity of mice on 3d (P<0.05), presenting a sedative effect.
3.6厚朴及厚朴汁炙远志的酚性成分含量测定3.6 Determination of phenolic components in Magnolia bark and Magnolia officinalis Juice
3.6.1实验材料及仪器3.6.1 Experimental materials and instruments
厚朴酚及和厚朴酚对照品(纯度均大于98.0%,成都曼斯特生物科技有限公司)、色谱甲醇为色谱纯,甲醇、纯净水等其他试剂均为分析纯。Magnolol and honokiol reference substances (purity greater than 98.0%, Chengdu Master Biotechnology Co., Ltd.), chromatographic methanol are chromatographically pure, methanol, purified water and other reagents are analytically pure.
岛津LC-20AT高效液相色谱仪(SHIAZDU公司),UV检测器,CP124S电子分析天平(SARTORIUS)。Shimadzu LC-20AT high performance liquid chromatography (SHIAZDU company), UV detector, CP124S electronic analytical balance (SARTORIUS).
3.6.2色谱条件和系统适应性试验3.6.2 Chromatographic conditions and system adaptability test
Boston Green ODS C18色谱柱(4.6×250mm,5μm,);流动相甲醇-水(78:22)为流动相;流速1ml·min-1;柱温:30℃;检测波长为294nm。分离度均大于1.5,理论塔板数按厚朴酚峰计算不低于3800。Boston Green ODS C18 column (4.6×250mm, 5μm, ); the mobile phase methanol-water (78:22) was the mobile phase; the flow rate was 1ml·min -1 ; the column temperature was 30°C; the detection wavelength was 294nm. The degree of separation is greater than 1.5, and the number of theoretical plates is not less than 3800 based on the peak of magnolol.
3.6.3样品的制备3.6.3 Sample preparation
混合对照品溶液的制备取厚朴酚对照品、和厚朴酚对照品适量,精密称定,加甲醇混合制成每1ml含厚朴酚40ug、和厚朴酚24ug的溶液,即得。所得色谱图如图1所示。Preparation of Mixed Reference Substance Solution Take appropriate amount of magnolol reference substance and honokiol reference substance, weigh them accurately, add methanol and mix to make a solution containing 40ug of magnolol and 24ug of honokiol per 1ml. The resulting chromatogram is shown in Figure 1.
供试品溶液的制备精密量取远志20分钟药液、厚朴10分钟药液、炮制品5各2ml,加甲醇定容至10ml容量瓶中,振摇。过0.45um微孔滤膜,即得。Preparation of the test solution Precisely measure Polygala 20-minute liquid, Magnolia officinalis 10-minute liquid, 5 processed products 2ml each, add methanol to a 10ml volumetric flask, and shake. Pass through a 0.45um microporous membrane to obtain it.
3.6.4阴性干扰试验3.6.4 Negative interference test
取3.6.3项下远志供试品10ul,依照3.6.2项下色谱条件进样,检测,未发现干扰。结果说明远志单味药液对厚朴药液成分的测定没有干扰,详见图2。Take 10ul of Polygala test sample under item 3.6.3, inject the sample according to the chromatographic conditions under item 3.6.2, detect and find no interference. The results showed that Polygala single herb liquid did not interfere with the determination of Magnolia officinalis liquid components, see Figure 2 for details.
3.6.5线性关系考察3.6.5 Linear relationship inspection
分别取3.6.3项下厚朴酚、和厚朴酚混合对照品2ul、4ul、6ul、8ul、10ul、12ul、18ul及浓度为每1ml含和厚朴酚48ug、厚朴酚80ug的混合对照品10ul进样,得到其质量与峰面积的关系,计算回归方程及R2值,和厚朴酚及厚朴酚的R2值均为0.9994,说明线性关系良好。结果见下表14、15及图3、4。Take respectively 2ul, 4ul, 6ul, 8ul, 10ul, 12ul, 18ul of magnolol and honokiol mixed reference substance under item 3.6.3 and the mixed control whose concentration is 48ug of honokiol and 80ug of magnolol per 1ml Product 10ul sample injection, obtain its mass and the relation of peak area, calculate regression equation and R2 value, the R2 value of honokiol and magnolol is 0.9994, shows that the linear relationship is good. The results are shown in Tables 14 and 15 and Figures 3 and 4 below.
表14和厚朴酚的质量与峰面积关系The mass and peak area relationship of table 14 honokiol
表15厚朴酚的质量与峰面积关系The mass and peak area relation of table 15 magnolol
3.6.6精密度试验3.6.6 Precision test
取3.6.3项下混合对照品溶液10ul,按照3.6.2项下色谱条件连续进样6针,得峰面积,并计算峰面积的RSD值。结果见表16。Take 10ul of the mixed reference substance solution under item 3.6.3, inject 6 needles continuously according to the chromatographic conditions under item 3.6.2, obtain the peak area, and calculate the RSD value of the peak area. The results are shown in Table 16.
表16混合对照品精密度试验Table 16 Mixed reference substance precision test
结果表明其RSD值均小于2%,故仪器精密度良好。The results showed that the RSD values were all less than 2%, so the precision of the instrument was good.
3.6.7稳定性试验3.6.7 Stability test
取3.6.3项下混合对照品及厚朴供试品10ul,按照3.6.2项下色谱条件分别于0、2、4、8、12、24h进样。得峰面积,并计算峰面积的RSD值,结果见表17、18。Take 10ul of the mixed reference substance and magnolia bark test substance under item 3.6.3, and inject samples at 0, 2, 4, 8, 12, and 24 hours respectively according to the chromatographic conditions under item 3.6.2. Get the peak area, and calculate the RSD value of the peak area, the results are shown in Tables 17 and 18.
表17混合对照品稳定性试验Table 17 Mixed reference substance stability test
表18厚朴供试品稳定性试验Table 18 Magnolia officinalis test product stability test
由结果可知,其RSD均小于2%,混合对照品及供试品溶液在24h内基本稳定。It can be seen from the results that the RSDs are all less than 2%, and the mixed reference substance and the test solution are basically stable within 24 hours.
3.6.8重复性试验3.6.8 Repeatability test
按照3.6.3项下厚朴供试品的制备平行制样6份,每份取10ul,按照3.6.2项下色谱条件进样。得峰面积,并计算峰面积的RSD值。结果见表19。Prepare 6 samples in parallel according to the preparation of the magnolia bark test product under item 3.6.3, take 10ul for each, and inject samples according to the chromatographic conditions under item 3.6.2. The peak area was obtained, and the RSD value of the peak area was calculated. The results are shown in Table 19.
表19厚朴供试品重复性试验Table 19 Magnolia bark test product repeatability test
结果显示,RSD值均小于3%,说明制样方法的重复性良好。The results showed that the RSD values were all less than 3%, indicating that the repeatability of the sample preparation method was good.
3.6.9加样回收率试验3.6.9 Sample recovery test
平行精密量取与6份含量测定相同的厚朴水煎液2ml,加入厚朴酚及和厚朴酚对照品适量,按照3.6.3项下供试品制备方法制备。每份取10ul按照3.6.2项下色谱条件进样。计算回收率及RSD值,所得结果如下表20、21所示。Parallel precision measure 2ml of Magnolia officinalis water decoction which is the same as the content determination of 6 parts, add magnolol and honokiol reference substance in appropriate amount, and prepare according to the preparation method of the test sample under 3.6.3. Take 10ul from each portion and inject according to the chromatographic conditions under 3.6.2. The recovery rate and RSD value were calculated, and the obtained results are shown in Tables 20 and 21 below.
表20和厚朴酚加样回收率试验Table 20 honokiol sample addition recovery test
表21厚朴酚加样回收率试验Table 21 Magnolol sample addition recovery test
结果显示,加样回收率在95%-105%范围内,RSD均小于2%。提示样品制备方法可行。The results showed that the recoveries were in the range of 95%-105%, and the RSDs were all less than 2%. Prompt sample preparation method is feasible.
3.6.10厚朴与厚朴汁炙远志的和厚朴酚及厚朴酚含量测定3.6.10 Determination of honokiol and magnolol content in Magnolia officinalis and Magnolia officinalis Zhizhi
按照3.6.3样品的制备方法,平行制备3份厚朴10分钟药液及炮制品5供试品,按照3.6.2色谱条件,进样10ul,每个样本平行进样3次。测定药液中的和厚朴酚及厚朴酚的平均含量和RSD值。所得结果如表22、23所示,厚朴酚10分钟药液及炮制品5酚性成分的色谱图如图5、6所示。According to the sample preparation method in 3.6.3, prepare 3 copies of Magnolia officinalis 10-minute medicinal solution and 5 test samples in parallel. According to the chromatographic conditions in 3.6.2, inject 10ul of sample, and inject 3 times in parallel for each sample. The average content and RSD value of honokiol and magnolol in the liquid medicine were determined. The obtained results are shown in Tables 22 and 23, and the chromatograms of the 10-minute medicinal solution of magnolol and the 5 phenolic components of the processed product are shown in Figures 5 and 6.
表22和厚朴酚含量测定结果Table 22 honokiol content assay results
表23厚朴酚含量测定结果Table 23 Magnolol Content Determination Results
由结果可知,RSD均在3%内。炮制品5与厚朴10分钟药液相比,和厚朴酚及厚朴酚含量略有降低。It can be seen from the results that the RSDs were all within 3%. The content of honokiol and magnolol in processed product 5 was slightly lower than that of Magnolia officinalis 10 minutes liquid.
3.7远志与厚朴汁炙远志的细叶远志皂苷含量测定3.7 Determination of Saponins in Polygala Polygalae and Magnolia officinalis Juice
3.7.1实验材料及仪器3.7.1 Experimental materials and instruments
细叶远志皂苷(纯度大于98.0%,成都曼斯特生物科技有限公司)、色谱甲醇为色谱纯,甲醇、纯净水、磷酸等其他试剂均为分析纯。Polygala saponin (purity greater than 98.0%, Chengdu Master Biotechnology Co., Ltd.), chromatographic methanol is chromatographically pure, methanol, purified water, phosphoric acid and other reagents are analytically pure.
岛津LC-20AT高效液相色谱仪(SHIAZDU公司),UV检测器,CP124S电子分析天平(SARTORIUS)。Shimadzu LC-20AT high performance liquid chromatography (SHIAZDU company), UV detector, CP124S electronic analytical balance (SARTORIUS).
3.7.2色谱条件和系统适应性试验3.7.2 Chromatographic conditions and system adaptability test
Boston Green ODS C 18色谱柱(4.6×250mm,5μm,);流动相甲醇-0.05%磷酸溶液(55:45)为流动相;流速1ml·min-1;柱温:30℃;检测波长为210nm。分离度大于1.5,理论塔板数按细叶远志皂苷峰计算不低于3000。Boston Green ODS C 18 chromatographic column (4.6×250mm, 5μm, ); the mobile phase methanol-0.05% phosphoric acid solution (55:45) is the mobile phase; the flow rate is 1ml·min -1 ; the column temperature is 30°C; the detection wavelength is 210nm. The degree of separation is greater than 1.5, and the number of theoretical plates is not less than 3000 based on the peak of polygala saponin.
3.7.3样品的制备3.7.3 Sample preparation
细叶远志皂苷对照品溶液的制备 取细叶远志皂苷对照品适量,精密称定,加甲醇制成每1ml含1mg的溶液,即得。所得色谱图如图7所示。Preparation of Polygala saponin Reference Substance Solution Take an appropriate amount of Polygala saponin reference substance, weigh it accurately, add methanol to make a solution containing 1 mg per 1 ml, and obtain it. The resulting chromatogram is shown in Figure 7.
供试品溶液的制备吸取经过静置的厚朴10分钟药液、远志20分钟药液、炮制品5各上清液,3000rmp离心10min后,精密量取各离心后药液5ml,加入11%氢氧化钠溶液50ml,配制成10%氢氧化钠溶液55ml,加热回流2小时,放冷,用盐酸调节pH值为4~5,用水饱和的正丁醇振摇提取3次,每次50ml,合并正丁醇液,回收溶剂至干,残渣加甲醇适量使溶解,转移至25ml量瓶中,加甲醇至刻度,摇匀。过0.45um微孔滤膜,即得。Preparation of the test solution Take the supernatants of Magnolia officinalis 10 minutes medicinal liquid, polygala 20 minutes medicinal liquid, and processed product 5 after standing, after centrifuging at 3000rmp for 10min, accurately measure 5ml of each centrifugal medicinal liquid, add 11% 50ml of sodium hydroxide solution was prepared into 55ml of 10% sodium hydroxide solution, heated and refluxed for 2 hours, allowed to cool, adjusted to pH 4-5 with hydrochloric acid, extracted by shaking with n-butanol saturated with water 3 times, 50ml each time, Combine the n-butanol solution, recover the solvent to dryness, add an appropriate amount of methanol to dissolve the residue, transfer it to a 25ml measuring bottle, add methanol to the mark, and shake well. Pass through a 0.45um microporous membrane to obtain it.
3.7.4阴性干扰试验3.7.4 Negative interference test
取3.7.3项下远志供试品10ul,依照3.7.2项下色谱条件进样,检测,未发现干扰。结果说明厚朴单味药液对远志药液成分的测定没有干扰,详见图8。Take 10ul of the Polygala test sample under item 3.7.3, inject the sample according to the chromatographic conditions under item 3.7.2, detect and find no interference. The results show that the single medicinal liquid of Magnolia officinalis does not interfere with the determination of the components of Polygala medicinal liquid, see Figure 8 for details.
3.7.5线性关系考察3.7.5 Linear relationship inspection
分别取3.7.3项下细叶远志皂苷对照品2ul、4ul、6ul、8ul、10ul、12ul、16ul进样,得到其质量与峰面积的关系,计算回归方程及R2值,细叶远志皂苷的R2值为0.9996,说明线性关系良好,结果见下表24及图9。Take 2ul, 4ul, 6ul, 8ul, 10ul, 12ul, and 16ul samples of the reference substance of Polygala saponin under item 3.7.3 respectively, obtain the relationship between its mass and peak area, calculate the regression equation and R 2 value, Polygala saponin The R2 value is 0.9996, indicating that the linear relationship is good, the results are shown in Table 24 and Figure 9 below.
表24细叶远志皂苷的质量与峰面积关系Table 24 The relationship between the quality and peak area of polygala saponins
3.7.6精密度试验3.7.6 Precision test
取3.7.3项下细叶远志皂苷对照品溶液10ul,按照3.7.2项下色谱条件连续进样6针,得峰面积,并计算峰面积的RSD值。结果见表25。Take 10ul of Polygala saponin reference solution under item 3.7.3, inject 6 needles continuously according to the chromatographic conditions under item 3.7.2, obtain the peak area, and calculate the RSD value of the peak area. The results are shown in Table 25.
表25细叶远志皂苷照品精密度试验Table 25 Precision Test of Polygala saponin
结果表明其RSD值均小于2%,故仪器精密度良好。The results showed that the RSD values were all less than 2%, so the precision of the instrument was good.
3.7.7稳定性试验3.7.7 Stability test
取3.7.3项下细叶远志皂苷对照品及远志供试品10ul,按照3.7.2项下色谱条件分别于0、2、4、8、12、24h进样。得峰面积,并计算峰面积的RSD值,结果见表26、27。Take 10ul of polygala saponin reference substance and polygala test sample under item 3.7.3, and inject samples at 0, 2, 4, 8, 12, and 24 hours respectively according to the chromatographic conditions under item 3.7.2. The peak area was obtained, and the RSD value of the peak area was calculated. The results are shown in Tables 26 and 27.
表26细叶远志皂苷对照品稳定性试验Table 26 Stability test of polygala saponin reference substance
表27远志供试品稳定性试验Table 27 Polygala test product stability test
由结果可知,其RSD均小于2%,细叶远志皂苷对照品及供试品溶液在24h内基本稳定。From the results, it can be seen that the RSDs were all less than 2%, and the solutions of polygala saponin reference substance and test solution were basically stable within 24 hours.
3.7.8重复性试验3.7.8 Repeatability test
按照3.7.3项下远志供试品的制备平行制样6份,每份取10ul,按照3.7.2项下色谱条件进样。得峰面积,并计算峰面积的RSD值。结果见表28。Prepare 6 samples in parallel according to the preparation of Polygala test sample under item 3.7.3, take 10ul for each, and inject samples according to the chromatographic conditions under item 3.7.2. The peak area was obtained, and the RSD value of the peak area was calculated. The results are shown in Table 28.
表28远志供试品重复性试验Table 28 Polygala test product repeatability test
结果显示,RSD值均小于3%,制样方法的重复性良好。The results showed that the RSD values were all less than 3%, and the repeatability of the sample preparation method was good.
3.7.9加样回收率试验3.7.9 Sample recovery test
平行精密量取与6份含量测定相同的远志水煎液5ml,加入细叶远志皂苷对照品适量,按照3.7.3项下供试品制备方法制备。每份取10ul按照3.7.2项下色谱条件进样。计算回收率及RSD值,所得结果如下表29所示。Parallel precision measure 5ml of Polygala water decoction same as 6 parts for content determination, add appropriate amount of Polygala saponin reference substance, and prepare according to the preparation method of the test sample under 3.7.3. Take 10ul from each portion and inject according to the chromatographic conditions under 3.7.2. The recovery rate and RSD value were calculated, and the obtained results are shown in Table 29 below.
表29细叶远志皂苷加样回收率试验Table 29 Polygala saponin sample recovery test
结果显示,加样回收率在95%-105%范围内,RSD小于3%。提示样品的制备方法可行。The results showed that the recovery rate was in the range of 95%-105%, and the RSD was less than 3%. The sample preparation method is suggested to be feasible.
3.7.10各药液中细叶远志皂苷的含量测定结果3.7.10 Determination results of the content of polygala saponin in each medicinal solution
按照3.7.3样品的制备方法,平行制备3份远志20分钟药液及炮制品5供试品,按照3.7.2色谱条件,进样10ul,每个样本平行进样3次。测定药液中的细叶远志皂苷的平均含量和RSD值。所得结果如表30所示,远志20分钟药液及炮制品5细叶远志皂苷的色谱图如图10、11所示。According to the sample preparation method in 3.7.3, prepare 3 copies of polygala 20-minute medicinal liquid and 5 test samples in parallel, and inject 10ul of sample according to chromatographic conditions in 3.7.2, and inject 3 times in parallel for each sample. The average content and RSD value of polygala saponin in the medicinal liquid were determined. The results obtained are shown in Table 30, and the chromatograms of the Polygala 20-minute liquid medicine and the processed product 5 polygala saponins are shown in Figures 10 and 11.
表30细叶远志皂苷含量测定结果Table 30 Determination results of polygala saponin content
结果显示,RSD均在3%内。炮制品5与远志20分钟药液相比,细叶远志皂苷含量略有升高。The results showed that the RSDs were all within 3%. Compared with Polygala 20-minute medicinal solution in processed product 5, the content of Polygala saponin was slightly increased.
通过正交表设计不同炮制、煎煮工艺,采用胃残留率、小肠炭末肠推进实验优选能降低远志胃肠动力抑制副作用的炮制工艺;采用药理学实验,考察各炮制品镇静、止咳作用以验证其药效;采用HPLC法,比较测定远志、厚朴及其优选炮制品的含量变化。Different processing and decocting processes were designed by orthogonal tables, and the processing technology that can reduce the side effects of Polygala gastrointestinal motility inhibition was selected by gastric residual rate and small intestine charcoal propulsion experiments; pharmacological experiments were used to investigate the sedative and antitussive effects of each processed product. To verify its medicinal effect; use HPLC method to compare and measure the content changes of Polygala, Magnolia officinalis and their preferred processed products.
结果:①各个炮制品中,炮制品5与煎煮20min、60min的单味远志组比较,能显著降低小鼠的胃残留率及增加肠推进率(P<0.05)。②优选出的炮制品5组能极显著地增强戊巴比妥钠协同镇静作用(P<0.01),其各剂量组还能显著降低小鼠的自主活动率(P<0.01,P<0.05);并能极显著地延长小鼠氨水所致咳嗽的咳嗽潜伏期(P<0.01),减少咳嗽次数(P<0.01),其30g/kg组能显著增加小鼠的气管内酚红吸光度及浓度(P<0.05)而有祛痰作用。③单味厚朴煎煮10min组的和厚朴酚与厚朴酚平均含量分别为0.100、0.153mg/g,炮制品5分别为0.073、0.111mg/g;而远志单煎20min组的细叶远志皂苷含量为2.650mg/g,炮制品5为3.840mg/g。Results: ① Among the processed products, processed product 5 could significantly reduce the gastric residual rate and increase the intestinal propulsion rate in mice compared with the single-flavor polygala group decocted for 20 minutes and 60 minutes (P<0.05). ② The optimized processed product group 5 can significantly enhance the synergistic sedative effect of pentobarbital sodium (P<0.01), and each dose group can also significantly reduce the autonomous activity rate of mice (P<0.01, P<0.05) ; and can significantly prolong the cough incubation period of cough caused by ammonia water in mice (P<0.01), reduce the number of coughs (P<0.01), and its 30g/kg group can significantly increase the absorbance and concentration of phenol red in the trachea of mice ( P<0.05) and has an expectorant effect. ③The average contents of honokiol and magnolol in the single-flavored magnolia decoction group for 10 minutes were 0.100 and 0.153 mg/g, respectively, and the processed product 5 were 0.073 and 0.111 mg/g respectively; The content of polygala saponin is 2.650mg/g, and that of processed product 5 is 3.840mg/g.
本发明厚朴炙远志炮制品最终选择采用以下方法制备:Magnolia Radix Polygalae processed product of the present invention finally selects and adopts the following method to prepare:
①厚朴汁制备:取厚朴药材70-130g,8-12倍量水浸泡15-45min,武火煮沸后文火煎煮5-15min,减压浓缩至10-40ml即为厚朴浓缩汁。①Preparation of magnolia juice: Take 70-130g of magnolia medicinal material, soak it in 8-12 times the amount of water for 15-45min, boil it with strong fire, then decoct it with slow fire for 5-15min, and concentrate it under reduced pressure to 10-40ml to get magnolia concentrated juice.
②厚朴汁炙远志:取远志药材30-70g,加入10-40ml厚朴浓缩汁闷润1-5h,60-180℃炒炙6-18min,干燥即得。② Sunburn Polygala with Magnolia Juice: Take 30-70g of Polygala medicinal material, add 10-40ml concentrated Magnolia officinalis juice to moisten for 1-5h, stir-fry at 60-180°C for 6-18min, and dry it.
炮制品5,即本发明厚朴炙远志炮制品的优选制备工艺如下:Processed product 5, the preferred preparation process of Magnolia officinalis Radix Polygalae processed product of the present invention is as follows:
①厚朴汁制备:取厚朴药材100g,8-12倍量水浸泡30min,武火煮沸后文火煎煮10min,减压浓缩至25ml即为厚朴浓缩汁。①Preparation of Magnolia officinalis juice: Take 100g of Magnolia officinalis medicinal material, soak it in 8-12 times the amount of water for 30 minutes, boil it with strong fire, then decoct it with slow fire for 10 minutes, and concentrate it under reduced pressure to 25ml, which is the concentrated Magnolia bark juice.
②厚朴汁炙远志:取远志药材50g,加入25ml厚朴浓缩汁闷润3h,120℃炒炙12min,干燥即得。②Steaming Polygala with Magnolia Juice: Take 50g of Polygala medicinal material, add 25ml of concentrated Magnolia officinalis juice and moisten for 3 hours, fry and broil at 120°C for 12 minutes, and dry it.
本发明炮制品煎煮条件:取上法制得的厚朴汁炙远志(理论生药量150g),加8-12倍水浸泡15-45min,武火煮沸后文火煎煮10-30min,减压浓缩,定容至100ml,相当于含原生药材总量1.5g/ml。The decocting conditions of the processed product of the present invention: take the Magnolia officinalis Juice prepared by the above method and roast Polygala (theoretical crude drug amount is 150g), add 8-12 times of water to soak for 15-45min, boil with strong fire, decoct with slow fire for 10-30min, concentrate under reduced pressure, Set the volume to 100ml, which is equivalent to 1.5g/ml of the total amount of raw medicinal materials.
优选煎煮条件为:取上法制得的厚朴汁炙远志(理论生药量150g),加10倍水浸泡30min,武火煮沸后文火煎煮20min,减压浓缩,定容至100ml,相当于含原生药材总量1.5g/ml。The optimal decocting conditions are: take Magnolia officinalis Juice Zhigala (theoretical crude drug amount 150g) prepared by the above method, add 10 times of water to soak for 30 minutes, boil it with strong fire, then decoct it with slow fire for 20 minutes, concentrate under reduced pressure, and set the volume to 100ml, which is equivalent to containing The total amount of raw medicinal materials is 1.5g/ml.
上述条件制备的远志炮制饮片,能有效降低生远志的胃肠动力抑制副作用,且能保留镇咳、祛痰、安神药效,达到了减副存效的目的,具有临床应用价值。The processed decoction pieces of Polygala prepared under the above conditions can effectively reduce the gastrointestinal motility inhibitory side effects of Polygala polygala, and can retain the effects of antitussive, expectorant, and tranquilizing drugs, achieving the purpose of reducing side effects and saving efficacy, and has clinical application value.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210482642.0A CN102920792B (en) | 2012-11-23 | 2012-11-23 | Processed product of polygala tenuifolia with mangnolia officinalis and preparation method of same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210482642.0A CN102920792B (en) | 2012-11-23 | 2012-11-23 | Processed product of polygala tenuifolia with mangnolia officinalis and preparation method of same |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102920792A CN102920792A (en) | 2013-02-13 |
CN102920792B true CN102920792B (en) | 2014-12-31 |
Family
ID=47635817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210482642.0A Expired - Fee Related CN102920792B (en) | 2012-11-23 | 2012-11-23 | Processed product of polygala tenuifolia with mangnolia officinalis and preparation method of same |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102920792B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105193956A (en) * | 2015-10-09 | 2015-12-30 | 江苏健生源中药材有限公司 | Preparation method of polygala root decoction pieces |
CN105687340A (en) * | 2016-03-28 | 2016-06-22 | 四川聚元中药饮片有限公司 | Processing technology of polygala root |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1954842A (en) * | 2005-10-26 | 2007-05-02 | 成都中医药大学 | Honey polygala and its preparation method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2411028T1 (en) * | 2009-03-27 | 2019-09-30 | Moleac Pte Ltd | Therapy for promoting cell growth |
-
2012
- 2012-11-23 CN CN201210482642.0A patent/CN102920792B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1954842A (en) * | 2005-10-26 | 2007-05-02 | 成都中医药大学 | Honey polygala and its preparation method |
Non-Patent Citations (4)
Title |
---|
江娟等,.远志与厚朴不同煎煮时间及不同配比对小鼠胃肠运动的影响.《西安交通大学学报( 医学版)》.2009,第30卷(第3期),第380-382页. * |
王正益,龚千峰主编.远志.《中药炮制学》.中国医药科技出版社,2001,(第1版),第240-241页. * |
田竞等,.厚朴与远志配伍对大鼠胃肠道消化功能的影响.《中药药理与临床》.2011,第27卷(第1期),第66-68页,3 讨论. * |
马晓燕等,.远志、厚朴及其不同配比对家兔离体肠平滑肌的影响.《中药药理与临床》.2011,第27卷(第3期),第91-93页,第92页 3 讨论. * |
Also Published As
Publication number | Publication date |
---|---|
CN102920792A (en) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103182016A (en) | Traditional chinese medicine composition and preparation method thereof | |
CN103263490A (en) | Extract from traditional Chinese medicine and its preparation method | |
CN103191246A (en) | Traditional chinese medicine extract and preparation method thereof | |
CN102920792B (en) | Processed product of polygala tenuifolia with mangnolia officinalis and preparation method of same | |
CN103223133A (en) | Traditional chinese medicine composition | |
CN107569612B (en) | A kind of medicine for improving sleep and preparation method thereof | |
CN103263450A (en) | Traditional Chinese medicine compositio | |
WO2013155995A1 (en) | Red yeast and kudzu root pharmaceutical composition for regulating blood lipids and preparation method therefor | |
CN102512485A (en) | Traditional Chinese medicine for treating acute hepatitis, chronic hepatitis and hepatic fibrosis | |
CN103272016A (en) | Traditional chinese medicine composition | |
CN107335029A (en) | A kind of preparation method of gut purge middle benefit gas particle | |
CN103202898B (en) | Traditional chinese medicine composition and preparation method thereof | |
CN103263491A (en) | Traditional chinese medicine composition | |
CN103202886B (en) | Traditional chinese medicine composition and preparation method thereof | |
CN101041000B (en) | Medicine compound for treating snoring and the preparing method thereof | |
CN105726947B (en) | A kind of improvement sleep, hypoglycemic acanthopanax radix polygonati officinalis leaf extract and its preparation method and application | |
CN103263492A (en) | Traditional chinese medicine extract | |
CN103211898A (en) | Traditional Chinese medicine extractive and preparation method thereof | |
CN103223082A (en) | Extract product of traditional Chinese medicine | |
CN103263475A (en) | Traditional chinese medicine composition | |
CN103223084A (en) | Traditional chinese medicine composition | |
CN102166337A (en) | Ginger and inula flower composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer | |
CN102688254B (en) | Medicinal composition for treating chronic diarrhea and preparation method and use thereof | |
CN103285110B (en) | Traditional Chinese medicine for treating hyperlipidemia and preparation method thereof | |
CN103263493A (en) | Traditional Chinese medicine composition and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141231 |